Clinical Trial Update: PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pembrolizumab in combination with chemoradiotherapy for squamous cell carcinoma of the head and neck; the trial was terminated and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma | Phase 1 | Status: TERMINATED | Results posted: 2025-12-18